Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Vaginal tablet with clindamycin and metronidazole

A technology of clindamycin and vaginal tablets, applied in pill delivery, organic active ingredients, diseases, etc., can solve the problems of inconvenient use, long cycle, high cost, etc.

Inactive Publication Date: 2006-02-15
程月发
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] 1. Systemic medication has a slow effect on local bacteria in the vaginal cavity, a long cycle, and large toxic and side effects on the body;
[0013] 2. For vaginal mixed infection of bacteria and trichomonas, there is no single compound preparation that is convenient to use and has a definite curative effect. Generally, 2-3 local preparations need to be applied, which is inconvenient to use and expensive;
[0014] 3. Because of the short residence time of Chinese herbal medicine, not only the effect is not obvious, but unreasonable washing may also destroy the acidic environment of the vagina, leading to bacterial imbalance and aggravating the development of the disease

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] prescription:

[0047] Clindamycin 1250g

[0048] Metronidazole 1000g

[0049] Microcrystalline Cellulose 600g

[0050] Cross-linked polyvinylpyrrolidone 300g

[0051] Polyvinylpyrrolidone 50g

[0052] Magnesium Stearate 45g

[0053] Made in 10000 pieces.

[0054] Preparation method: mix clindamycin, metronidazole, microcrystalline cellulose, and cross-linked polyvinylpyrrolidone evenly, granulate with 5% PVP ethanol solution, dry at 50-60°C, add magnesium stearate to the dry granules , whole grain, compressed tablet.

Embodiment 2

[0056] prescription:

[0057] Clindamycin 1250g

[0058] Metronidazole 1000g

[0059] Starch 500g

[0060] Microcrystalline Cellulose 400g

[0061] Low-substituted hydroxypropyl cellulose 500g

[0062] Magnesium Stearate 40g

[0063] Made in 10000 pieces.

[0064] Preparation method: Mix clindamycin, metronidazole, starch, microcrystalline cellulose, and low-substituted hydroxypropyl cellulose evenly, granulate with ethanol solution, dry at 50-60°C, add magnesium stearate to the dry granules , whole grain, compressed tablet.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a vaginal tablet of clindamycinum and metronidazole, which uses the salts or esters of clindamycinum and metronidazole as the active constituents, and the conventional tablets as the auxiliary material.

Description

Technical field: [0001] The invention relates to a vaginal tablet of clindamycin and metronidazole, which belongs to the field of chemical medicines. Background technique: [0002] Vaginitis is a common clinical disease in obstetrics and gynecology. A variety of pathogenic microorganisms can cause female reproductive tract infections. Common vaginitis is; Bacterial vaginosis, Trichomonas vaginitis, Candida albicans (fungal) vaginitis. [0003] G in normal vagina + Bacillus, G - Bacillus, G + Cocci, G - coccus; and other microorganisms such as Mycoplasma hominis, Ureaplasma, yeast, etc. Under the balance of flora, it will not cause disease. Whenever the ecological environment of the vagina changes and the immune function of the vagina is out of balance, the flora in the normal vagina is out of balance or infected with pathogenic pathogens, the vagina is prone to various vaginitis. [0004] Bacterial vaginosis (Bacterial vaginosis, BV) is the most common vaginal infecti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7048A61K9/20A61P15/02A61K31/4164
Inventor 程月发王国勒周文艳盛四龙
Owner 程月发
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products